What each format physically is
After synthesis, cleavage, purification and lyophilization, a GLP-1-family peptide is a dry cake or free-flowing powder in a primary container, and that released bulk is what QC samples for the batch certificate. Raw powder and vials are two ways of subdividing it, not two products.
Bulk raw powder
Raw powder is the released lyophilizate in a sealed primary container, typically an amber glass bottle or a polymer container with a screw cap, inner seal and tamper-evident closure. One label carries the product name, lot alias, net mass and research-use line; everything else lives on the certificate. The buyer opens it, weighs out what is needed and manages the rest from then on.
Lyophilized vials
Vials are the same bulk dispensed to a target fill mass into individual glass vials, stoppered, crimped, inspected, labeled with the same lot alias and a strength, and packed as kits of ten. The weighing step moves from the buyer's bench to Pepti's fill line, and the buyer receives sealed units rather than an opened container.
The vial format here is a dry fill of released powder, not a solution lyophilized in the vial, so a vial shows loose powder or a compacted bed rather than a uniform cake, and the powder has met the fill environment once before it reaches you. That matters for the moisture discussion below.
One lot code across both formats
The lot alias is assigned at bulk release and does not change when part of that bulk is filled into vials. Powder and vials from the same bulk share one certificate with the same HPLC and MS results, because the analysis was performed on the bulk, not on each subdivision. Public records on peptioem.com show the pattern: PEP260819-RT20 is retatrutide at 20 mg per vial, 99.26% by HPLC, manufactured 2026-08-19 and tested 2026-08-22.
How a vial fill is documented against the bulk certificate
Filling generates its own record, and that record points back to the bulk. It names the bulk lot alias, the target fill mass per vial, the balance used, the stopper and crimp components, the count of vials filled and the reconciliation of powder dispensed against powder consumed, with a fill-weight check on sampled vials. Ask for it with the certificate: the certificate says what the bulk is, the fill record says how much is in each vial, and without it there is no documented link between a label strength and a weighed mass.
Why the alias on the label must match the certificate
The alias on the vial label, the kit box, the certificate and the courier paperwork should be identical strings; a different strength suffix, a transposed digit or an alias missing from the certificate is a reason to hold the shipment and ask. The quality and batch-records page explains how aliases map to published records; at receiving, the check is that the string on the glass is the string on the paper.
Who chooses raw powder and who chooses vials
The choice follows from who does the weighing and who needs unit-level traceability, not from the chemistry. Both formats are manufactured by Pepti, Guangzhou from the same released bulk, so the decision is about the workflow on the receiving side.
Raw powder suits groups that weigh their own aliquots
Research groups with a trained analyst and a suitable balance usually prefer bulk: they weigh the masses their protocols call for, label aliquots with their own identifiers and keep one opened container under their own stock control. Fill-finish partners take bulk because they fill their own vials under their own records, with the Pepti certificate as the incoming-material document. Laboratories doing method development or reference-standard work consume more mass than a vial holds and prefer one container.
Vials suit laboratories and distributors that want unit-level handling
Laboratories without a dedicated weighing setup, or that want each unit sealed until needed, take vials: each unit is closed, labeled and traceable on its own, with no opened container to manage. Distributors take vials because a kit is a sealed, labeled, countable unit that can be allocated downstream with its certificate and fill record attached. QA functions that reconcile inventory by unit rather than by mass also find vials simpler to audit.
Units, minimums and vial strengths
Pepti quotes in units that map to the two formats. The vial unit is a kit, and 1 kit = 10 vials; the powder unit is mass.
- Sample order: 1 kit (10 vials), the entry point for identity and purity checks on sealed units before committing to volume.
- Private-label OEM: 50 kits (500 vials), the volume from which the kit can carry the buyer's own artwork.
- Bulk raw powder: from 5 g, shipped cold-chain, as a sealed primary container with the bulk certificate.
- Custom sequence: 100 kits (1,000 vials), typically about 15 days after specification and payment confirmation; a new synthesis with its own lot and certificate.
Vial strengths with public records
Published records cover semaglutide from 5 mg to 50 mg per vial; tirzepatide and retatrutide from 5 mg to 100 mg; cagrilintide and mazdutide at 5 mg and 10 mg. The library held 76 entries as checked on 2026-10-19, and the semaglutide, tirzepatide and mazdutide pages list the public records for each compound. A strength without a public record is not necessarily unavailable, but it is a new fill with a new fill record, usually scheduled in the production-batch range rather than the sample-kit range.
Bulk powder has no strength: the label states net mass and the buyer decides the subdivisions, so for a mass per unit that is not on the public ladder, bulk and your own weighing may be faster than waiting for a custom fill.
Weighing lyophilized powder and what moisture does to the number
Lyophilized peptide is a porous, high-surface-area solid, and GLP-1-family peptides carry polar side chains and a counter-ion (acetate or trifluoroacetate) that bind water readily. An open container picks up moisture from laboratory air during the time it takes to weigh it, and the mass on the balance rises while you watch: the largest single source of disagreement between a weighed mass and the certificate.
What a weighed mass includes
The number on the balance is peptide plus water plus counter-ion plus residual solvent. The certificate separates these: HPLC purity is an area-percent of the peptide-related peaks, water by Karl Fischer titration and counter-ion are mass fractions, and net peptide content is the fraction of the weighed solid that is peptide. Apply the net content to convert a weighed mass to a peptide mass, remembering that the correction holds only for the powder as released, before the container was opened.
Net content versus label claim: a public example
Janoshik Analytical report #210105 describes a Retatrutide 20 mg sample from Pepti with 19.52 mg content and 99.837% purity, analyzed 2026-10-07, verifiable at verify.janoshik.com. The purity figure describes the quality of the peptide; the content figure is the measured peptide mass in that vial against a label strength of 20 mg. The gap between them is where fill tolerance, water and counter-ion sit: a label strength is a target, a content result is a measurement. The report is sample-specific, one submitted vial, and not a claim about other lots or strengths.
Practical weighing for bulk powder
Let the sealed container reach room temperature before opening so condensation does not form on cold powder. Weigh by difference from a tared, closed vessel, work briskly and record ambient humidity with the mass. Reseal under dry nitrogen or argon if available, aliquot once into pre-labeled containers rather than reopening the bulk, and where an accurate peptide mass matters, assay the aliquot by HPLC against a reference rather than trusting the balance once the container has been opened.
Labels: neutral by default, private label at the OEM minimum
Vials and kits ship with a neutral Pepti label by default: it states what the material is and where it came from and carries no claims, meaning product name, lot alias, strength per vial, a storage line, the research-use line and the manufacturer identity. Raw powder containers carry the same fields with net mass in place of strength.
Private-label artwork under the OEM minimum
From 50 kits (500 vials), a buyer can supply artwork for the vial label and the kit box. The artwork is checked against the mandatory fields and the proof approved before the fill is scheduled, because a label change after filling means relabeling sealed units under a correction record; that approval is part of the OEM lead time.
What stays on every label
Whatever the artwork, a short set of fields does not move: the product name as the compound INN, the lot alias as it appears on the certificate, the strength per vial (or net mass for bulk), and the research-use line, which on Pepti material reads: For research use only. Not for human or veterinary use. The lot alias is what makes the label traceable to a record; a private label that omits it or replaces it with the buyer's own code breaks the link to the certificate and fill record, so if a buyer needs its own code, print both.
Lead-time implications of filling
Lead time depends on whether the bulk already exists and whether a fill has to be scheduled. The ladder Pepti quotes against: sample kits typically 5–10 days; a production batch typically 14–21 days; an OEM repeat order typically 21–28 days; a custom sequence typically about 15 days after specification and payment confirmation. These are typical ranges confirmed on each quote, not fixed commitments.
Why vial filling adds time to a raw-powder order
If released bulk is in stock, a raw-powder order needs only subdivision into the requested mass, a container label, a copy of the certificate and cold-chain packing. A vial order from the same bulk also needs the fill line scheduled, the fill performed and reconciled, vials inspected, labels applied, kits boxed, the fill record completed and the certificate issued for the vial lot. Each step is short, but they run in sequence and share a line with other fills.
If no bulk is in stock, synthesis dominates and both formats wait for the production batch; the difference reappears after release, when a buyer with weighing capacity can take powder while the vial fill from the same batch is still in the queue.
Cold chain and receiving for each format
Both formats ship cold-chain from Guangzhou in an insulated carton with gel packs or dry ice, chosen by route and season. The outer carton carries the courier label, the inner carton the lot alias, and the primary container or kit box the product label.
Receiving raw powder
Check the coolant state and the primary container seal first, then match the lot alias across courier label, inner carton, container label and certificate. Log the lot with the date received and the labeled mass, and store the container sealed. Commonly used conditions for sealed lyophilized peptide are −20 °C for longer holds and 2–8 °C for short holds; follow the storage line on the certificate for the lot you hold rather than a general rule.
Receiving vials
Count the vials against the kit label (1 kit = 10 vials), check that each crimp is intact and each stopper seated, and confirm the alias and strength on each vial match the kit box and the certificate. Log the kit as a unit and, if your system allows, each vial as a sub-unit so a single vial can be traced when issued. Sealed vials go to the same commonly used conditions as bulk; an issued vial is opened once and consumed, so the moisture concern is limited to that moment.
Whichever format arrives, photograph the open carton with coolant and labels visible before discarding the packing; if anything disagrees with the certificate, that photograph and the lot alias are what Pepti will ask for first.
Decision table and a recommendation for a first order
A chemistry row is deliberately absent from the table: identity, purity and the certificate are the same for both formats.
| Criterion | Bulk raw powder | Lyophilized vials |
|---|---|---|
| Traceability | One alias on one container; subdivisions traced by the buyer's aliquot log | One alias on every vial and kit; fill record links each unit to the bulk certificate |
| Minimum | From 5 g, shipped cold-chain | 1 kit (10 vials); private label from 50 kits (500 vials) |
| Labeling | Neutral container label with net mass | Neutral by default; buyer artwork at the OEM minimum |
| Weighing burden | Buyer: balance, humidity control, aliquoting, net-content correction | Pepti's fill line; buyer treats strength as a target and assays content if needed |
| Lead time | Subdivision of released stock; shortest when bulk exists | Adds fill scheduling and documentation; sample kits typically 5–10 days |
| First sample | Only with an existing weighing procedure | Usual choice: sealed units, unit-level traceability, 1 kit (10 vials) |
A recommendation for a first order
Order 1 kit (10 vials), run identity and purity checks on the sealed units against the certificate, then decide on bulk once your laboratory has a written weighing and aliquoting procedure. The capabilities page lists what Pepti can fill and label; the quality page explains the records that accompany both formats.
Sources and verification
- Janoshik Analytical report #210105 (Retatrutide 20 mg) — 19.52 mg content, 99.837% purity, analyzed 2026-10-07; sample-specific, not a claim about other lots
- Pepti COA record PEP260819-RT20 — Retatrutide 20 mg, 99.26% by HPLC, manufactured 2026-08-19, tested 2026-08-22
- Pepti COA record PEP260722-TR30 — Tirzepatide 30 mg, 99.7% by HPLC, manufactured 2026-07-22, tested 2026-07-29
- Pepti public COA library — 76 entries as checked 2026-10-19